Although the effects of adiponectin as a potent insulin sensitizer and immune modulator are well-known, we show for the first time that adiponectin has the ability to modulate T cell functions in the context of obesity. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.